Thoracic circumference: A new outcome measure in spinal muscular atrophy type 1?

被引:10
|
作者
Ropars, Juliette [1 ,2 ]
Barnerias, Christine [3 ]
Hully, Marie [3 ]
Chabaliere, Delphine [3 ]
Peudenier, Sylviane [1 ]
Barzic, Audrey [1 ]
Cros, Pierrick [1 ]
Desguerre, Isabelle [3 ]
机构
[1] CHRU Brest, Serv Pediat, 2 Ave Foch, F-29609 Brest, France
[2] INSERM, Lab Traitement Informat Med, U1101, Brest, France
[3] Hop Necker Enfants Malad, AP HP, Paris, France
关键词
Spinal muscular atrophy; Neuromuscular disorder; Outcome measure; Respiratory function; Disease progression; SHAM CONTROL; SMA; INFANTS; CARE; NUSINERSEN; CONSENSUS; SURVIVAL;
D O I
10.1016/j.nmd.2019.03.003
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Since respiratory insufficiency is the first cause of morbidity and mortality in spinal muscular atrophy type 1 (SMA 1), specific respiratory outcome measures are needed to evaluate changes and assess innovative therapies. In this study, thoracic circumference (TC) was used as a proxy for chest growth and an indirect measurement of respiratory function. The anthropometric parameters including TC and head circumference (HC) were evaluated from birth to 13 months in 19 infants with SMA 1 and 124 control infants. TC was significantly decreased in the SMA 1 group from the first weeks of life. The control group TC/HC ratio =1 ( 0.04), and was not found to be associated with age. By contrast, it decreased with time in all infants with SMA 1 and those with a TC/HC ratio <0.85 died within 3 months. TC is a simple measurement that provided an index of chest growth and was used as evidence of early, progressive respiratory failure and under-development of the rib-cage in SMA 1. The TC/HC ratio decreased in all patients over time, reflecting the progression of the disease suggesting that TC/HC ratio could be a new measure for SMA 1 for measuring disease severity and prognosis. (C) 2019 Elsevier B.Y. All rights reserved.
引用
收藏
页码:415 / 421
页数:7
相关论文
共 50 条
  • [1] The neuromuscular gross motor outcome as an outcome measure in spinal muscular atrophy
    Alfano, L.
    Miller, N.
    Iammarino, M.
    Lowes, L.
    NEUROMUSCULAR DISORDERS, 2019, 29 : S105 - S105
  • [2] Defining outcome measures for clinical trials in spinal muscular atrophy, type 1
    Finkel, RS
    Bönnemann, CG
    Weiner, DJ
    Mayer, OH
    Panitch, HB
    Traeger, N
    Glanzman, AM
    Flickinger, JM
    Medne, L
    Schadt, K
    Zemel, B
    Leonard, DGB
    Dreyfuss, G
    NEUROMUSCULAR DISORDERS, 2004, 14 (8-9) : 596 - 596
  • [3] Respiratory outcome of spinal muscular atrophy type 1 patients treated with nusinersen
    Ergenekon, Almala Pinar
    Yegit, Cansu Yilmaz
    Cenk, Muruvvet
    Gokdemir, Yasemin
    Eralp, Ela Erdem
    Ozturk, Gulten
    Unver, Olcay
    Coskun, Ozge Kenis
    Saygi, Evrim Karadag
    Turkdogan, Dilsad
    Karadag, Bulent
    PEDIATRICS INTERNATIONAL, 2022, 64 (01)
  • [4] The gross motor function measure™ is a valid and sensitive outcome measure for spinal muscular atrophy
    Nelson, Leslie
    Owens, Hollis
    Hynan, Linda S.
    Iannaccone, Susan T.
    NEUROMUSCULAR DISORDERS, 2006, 16 (06) : 374 - 380
  • [5] Risdiplam in Type 1 Spinal Muscular Atrophy
    Baranello, Giovanni
    Darras, Basil T.
    Day, John W.
    Deconinck, Nicolas
    Klein, Andrea
    Masson, Riccardo
    Mercuri, Eugenio
    Rose, Kristy
    El-Khairi, Muna
    Gerber, Marianne
    Gorni, Ksenija
    Khwaja, Omar
    Kletzl, Heidemarie
    Scalco, Renata S.
    Seabrook, Timothy
    Fontoura, Paulo
    Servais, Laurent
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (10): : 915 - 923
  • [6] Risdiplam in Type 1 Spinal Muscular Atrophy
    Krandick, Guido
    MONATSSCHRIFT KINDERHEILKUNDE, 2021, 169 (11) : 995 - 997
  • [7] SPINAL MUSCULAR ATROPHY FUNCTIONAL COMPOSITE SCORE: A FUNCTIONAL MEASURE IN SPINAL MUSCULAR ATROPHY
    Montes, Jacqueline
    Glanzman, Allan M.
    Mazzone, Elena S.
    Martens, William B.
    Dunaway, Sally
    Pasternak, Amy
    Riley, Susan O.
    Quigley, Janet
    Pandya, Shree
    De Vivo, Darryl C.
    Kaufmann, Petra
    Chiriboga, Claudia A.
    Finkel, Richard S.
    Tennekoon, Gihan I.
    Darras, Basil T.
    Pane, Marika
    Mercuri, Eugenio
    Mcdermott, Michael P.
    MUSCLE & NERVE, 2015, 52 (06) : 942 - 947
  • [8] Spinal Muscular Atrophy Type 1 Survival Without New Pharmacotherapies
    Bach, John R.
    Saporito, Louis
    Weiss, William
    AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION, 2024, 103 (03) : 233 - 237
  • [9] Muscle ultrasound imaging as a potential outcome measure in adult spinal muscular atrophy
    Bortolani, S.
    Capacchione, P.
    Vercelli, L.
    Ferraro, M.
    Dimanico, U.
    Mongini, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 501 - 501
  • [10] Choosing Life with Spinal Muscular Atrophy Type 1
    Moran Lavie
    Hodaya Nisnkorn
    Liora Sagi
    Israel Amirav
    Advances in Therapy, 2020, 37 : 1708 - 1713